SMARCA1 and cancer: To determine whether the phenotypic dosage sensitivity seen in cancer and C. elegans mesodermal (M) cell development is indeed characteristic of SWI/SNF in the promotion of AC invasion [31], we modulated expression of GFP::SWSN-4 using a combination of RNAi-mediated knockdown and AC-specific GFP-targeting nanobody technology.